MediLink Therapeutics focuses on developing competitive drug conjugates internationally. With independent intellectual property rights, MediLink Therapeutics develops the next generation of conjugate technologies. The future products will provide better therapeutic windows for the unmet clinical needs. MediLink Therapeutics strives to upgrade technologies, establish diverse technology platforms for drug conjugates, and expand into new disease areas to serve global patients continuously.

Biotechnology

Pharmaceutical

Therapeutics

MediLink Therapeutics

MediLink Therapeutics' headquarters in Suzhou, China

Description

People

Jobs